piperidine has been researched along with piperazine in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.44) | 18.7374 |
1990's | 1 (2.44) | 18.2507 |
2000's | 10 (24.39) | 29.6817 |
2010's | 21 (51.22) | 24.3611 |
2020's | 8 (19.51) | 2.80 |
Authors | Studies |
---|---|
Fotsch, C; St Jean, DJ | 1 |
Barthalmus, GT; Mitchell, MK; Noga, EJ | 1 |
DeGrado, WF; Jackson, S; Mousa, S; Olson, RE; Rafalski, M; Rockwell, A; Roderick, J; Xue, CB | 1 |
Hasegawa, S; Hirota, TK; Komoto, T; Kotake, J; Koya, H; Otsuka, M; Sakamoto, T; Sato, S | 1 |
Das, MM; Lalitha, M; Murthy, BN; Prabhakar, T; Rao, GB; Rao, NS | 1 |
Farrell, N; Gibson, D; Moshel, O; Najajreh, Y; Peleg-Shulman, T | 1 |
Chen, KH; Liao, WS; Lin, CE; Lin, WY | 1 |
Durgun, M; Emul, M; Innocenti, A; Scozzafava, A; Supuran, CT; Turkmen, H; Vullo, D; Yilmaztekin, S | 1 |
Alonso, C; Fuertes, MA; Gibson, D; Iborra, S; Martínez, E; Najajreh, Y; Nguewa, PA; Pérez, JM | 1 |
Kim, JY; Mehanna, AS | 1 |
Dios, R; Fiorentino, A; Gilbert, KM; Misra, M; Pandit, D; Venanzi, CA | 1 |
Ahn, K; Beidler, D; Bhattacharya, K; Cravatt, BF; Johnson, DS; Kamtekar, S; Lazerwith, S; Liimatta, M; Long, JZ; McKinney, MK; Mileni, M; Sadagopan, N; Smith, SE; Stevens, RC; Stiff, C; Swaney, S; Van Becelaere, K; Weerapana, E; Zhang, Y | 1 |
Andrésson, T; Bedell, L; Bhagat, N; Gurney, M; Halldorsdottir, G; Kiselyov, A; Mamat, B; Sandanayaka, V; Sigthorsdottir, H; Singh, J | 1 |
Gilbert, KM; Misra, M; Pandit, D; Roosma, W; Skawinski, WJ; Venanzi, CA | 1 |
Arora, J; Balestra, M; Breysse, N; Brockel, B; Brown, DG; Brugel, TA; Brush, KA; Chhajlani, V; Gadient, RA; Hightower, C; Hinkley, L; Hoesch, V; Isaac, M; Kang, J; King, MM; Koether, GM; McCauley, JP; McLaren, FM; Panko, LM; Simpson, TR; Slassi, A; Smith, RW; Spear, N; Sygowski, LA; Wilson, JM; Woods, JM; Xiong, H; Zhang, M | 1 |
Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jenh, CH; Jiang, Y; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shao, Y; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q | 1 |
Chonan, T; Hiratate, A; Io, F; Koretsune, H; Ohoka-Sugita, A; Oi, T; Tanaka, H; Wakasugi, D; Yamamoto, D; Yashiro, M | 1 |
Barlocco, D; Costantino, L | 1 |
Lokanatha Rai, KM; Prashanth, MK; Revanasiddappa, HD; Veeresh, B | 1 |
Christ, F; Debnath, B; Debyser, Z; Kuang, Y; Neamati, N; Otake, H; Serrao, E | 1 |
Aaltonen, N; Häyrinen, J; Käsnänen, H; Korhonen, J; Kuusisto, A; Laitinen, JT; Laitinen, T; Lehtonen, M; Navia-Paldanius, D; Nevalainen, T; Pantsar, T; Pasonen-Seppänen, S; Poso, A; Ribas, CR; Rönkkö, J; Savinainen, JR; Takabe, P | 1 |
Amanlou, M; Arjmand, M; Daha, FJ; Ghandi, M; Hasani Bozcheloie, A; Sadeghzadeh, M; Sheibani, S | 1 |
Bahadur, V; Falabella, M; Giuffrè, A; Kumar, Y; Mastronicola, D; Pucillo, LP; Sarti, P; Singh, BK; Tiwari, HK | 1 |
Hu, MJ; Li, Q; Liu, RY; Ma, TZ; Ma, WF; Yang, HK; You, WW; Zhao, PL; Zhou, ZZ | 1 |
Korhonen, J; Kuusisto, A; Laitinen, JT; Laitinen, T; Navia-Paldanius, D; Nevalainen, TJ; Parkkari, T; Patel, JZ; Savinainen, JR; van Bruchem, J | 1 |
Albert, CR; Bringmann, G; Bruhn, H; Buechold, C; Cecil, A; Engstler, M; Fuß, A; Goebel, T; Holzgrabe, U; Krohne, G; Mathein, D; Merget, B; Ponte-Sucre, A; Schirmeister, T; Schlesinger, S; Sotriffer, CA; Stich, A; Tischer, M | 1 |
Atobe, M; Bond, PS; Fairlamb, IJ; Haji-Cheteh, C; Hubbard, RE; Lüthy, M; O'Brien, P; Wheldon, MC | 1 |
Jewell, KS; Lutze, HV; Reisz, E; Schmidt, TC; Schmidt, W; Tekle-Röttering, A; Ternes, TA | 1 |
Beno, BR; Chaturvedula, PV; Civiello, RL; Conway, CM; Dubowchik, GM; Han, X; Herbst, JJ; Macor, JE; Xu, C | 1 |
Kantevari, S; Pulipati, L; Sriram, D; Yogeeswari, P | 1 |
Gloanec, P; Goument, B; Hanessian, S; Hocine, S; Le Tiran, A; Maertens, G; Mirguet, O; Öney, E; Reyes, MAV; Saavedra, OM; Vece, V | 1 |
Adhikari, N; Amin, SA; Bobde, Y; Ganesh, R; Ghosh, B; Jha, T; Trivedi, P | 1 |
De Luca, L; Garon, A; Germanò, MP; Gitto, R; Ielo, L; Langer, T; Pace, V; Rapisarda, A; Seidel, T; Vittorio, S | 1 |
Bashetti, N; Damuka, N; Devanathan, S; Mintz, A; Prasanna, B; Seelam, NV; Shanmukha Kumar, JV; Solingapuram Sai, KK | 1 |
Aoyama, H; Doura, T | 1 |
Abe, H; Asawa, Y; Katsuragi, K; Makino, K; Nakamura, H; Nomura, M; Ogino, Y; Okazawa, M; Oyama, T; Sakamoto, Y; Sato, A; Shibasaki, Y; Takahashi, H; Tanuma, N; Tanuma, SI; Uchiumi, F; Yamazaki, H; Yoshimori, A | 1 |
Chen, Y; Gao, L; Hu, J; Huang, L; Song, T; Yin, L; Zhang, X | 1 |
Albericio, F; Álvarez, C; Cárdenas, C; Gauna, A; Guzmán, F; Luna, O; Román, T | 1 |
Agarwal, S; Asati, V; Bhattacharya, S; Kashaw, SK; Mallick, C; Parwani, D; Rathore, A | 1 |
Bednarski, M; Bresinsky, M; Elz, S; Höring, C; Karcz, T; Kieć-Kononowicz, K; Kotańska, M; Kuder, KJ; Latacz, G; Mika, K; Mönnich, D; Nagl, M; Pockes, S; Podlewska, S; Seibel, U; Siwek, A; Stark, H; Szczepańska, K | 1 |
Bozzola, T; Ellervik, U; Johnsson, RE; Nilsson, UJ | 1 |
3 review(s) available for piperidine and piperazine
Article | Year |
---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
Ghrelin receptor modulators and their therapeutic potential.
Topics: Azoles; Drug Discovery; Ghrelin; Humans; Piperazine; Piperazines; Piperidines; Receptors, Ghrelin; Spiro Compounds; Structure-Activity Relationship | 2009 |
The Recent Development of Piperazine and Piperidine Derivatives as Antipsychotic Agents.
Topics: Animals; Antipsychotic Agents; Humans; Piperazine; Piperidines; Structure-Activity Relationship | 2021 |
38 other study(ies) available for piperidine and piperazine
Article | Year |
---|---|
Cyclic amines are selective cytotoxic agents for pigmented cells.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Drug Synergism; Melanins; Melanoma; Mice; Morpholines; Pigmentation; Piperazine; Piperazines; Piperidines; Theophylline | 1986 |
Design, synthesis, and in vitro activities of benzamide-core glycoprotein IIb/IIIa antagonists: 2,3-diaminopropionic acid derivatives as surrogates of aspartic acid.
Topics: Alanine; Alkylation; Animals; Aspartic Acid; Benzamides; Benzamidines; Benzoates; Benzoic Acid; beta-Alanine; Carbamates; Esterases; Humans; Liver; Magnetic Resonance Spectroscopy; Oligopeptides; Piperazine; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship; Sulfonamides; Swine | 1997 |
New strong fibrates with piperidine moiety.
Topics: Animals; Disease Models, Animal; Hypercholesterolemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Piperazine; Piperazines; Piperidines; Propionates; Rats; Rats, Sprague-Dawley | 2000 |
Natural abundance nitrogen-15 nuclear magnetic resonance spectral studies on selected donors.
Topics: Amines; Heterocyclic Compounds; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Morpholines; Nitrogen Isotopes; Piperazine; Piperazines; Piperidines; Solvents | 2002 |
Ligand effects on the binding of cis- and trans-[PtCl(2)Am(1)Am(2)] to proteins.
Topics: Amines; Animals; Binding Sites; Horses; Hydrogen Bonding; Isomerism; Ligands; Methionine; Myoglobin; Organoplatinum Compounds; Picolines; Piperazine; Piperazines; Piperidines; Protein Binding; Protein Folding; Spectrometry, Mass, Electrospray Ionization; Static Electricity; Ubiquitin | 2003 |
Influence of pH on electrophoretic behavior of phenothiazines and determination of pKa values by capillary zone electrophoresis.
Topics: Buffers; Cyclodextrins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Phenothiazines; Piperazine; Piperazines; Piperidines; Promethazine; Stereoisomerism | 2003 |
Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
Topics: Acetazolamide; Amines; Biomarkers, Tumor; Carbonic Anhydrase Inhibitors; Catalysis; Cytosol; Heterocyclic Compounds; Humans; Isoenzymes; Morpholines; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides | 2005 |
Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Butylamines; Cations; Cisplatin; DNA; Leishmania infantum; Molecular Sequence Data; Picolines; Piperazine; Piperazines; Piperidines; Platinum Compounds; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Ubiquitin; Water | 2005 |
Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers.
Topics: Animals; Aorta; Calcium Channel Blockers; Calcium Channels; Diltiazem; Drug Design; Male; Molecular Structure; Piperazine; Piperazines; Piperidines; Rats; Rats, Wistar; Salicylamides; Structure-Activity Relationship | 2005 |
Singular value decomposition of torsional angles of analogs of the dopamine reuptake inhibitor GBR 12909.
Topics: Computer Simulation; Dopamine Uptake Inhibitors; Molecular Structure; Piperazine; Piperazines; Piperidines | 2006 |
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Crystallography, X-Ray; Endocannabinoids; Enzyme Inhibitors; Humans; Male; Pain; Piperazine; Piperazines; Piperidines; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Structure-Activity Relationship; Urea | 2009 |
Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
Topics: Anti-Inflammatory Agents; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship | 2010 |
Conformational analysis of piperazine and piperidine analogs of GBR 12909: stochastic approach to evaluating the effects of force fields and solvent.
Topics: Models, Chemical; Piperazine; Piperazines; Piperidines; Solvents | 2011 |
4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
Topics: Allosteric Regulation; Amides; Humans; Microsomes, Liver; Piperazine; Piperazines; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Schizophrenia; Structure-Activity Relationship | 2010 |
II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.
Topics: Humans; Inhibitory Concentration 50; Molecular Structure; Piperazine; Piperazines; Piperidines; Pyridines; Receptors, CXCR3; Structure-Activity Relationship | 2011 |
Discovery of novel (4-piperidinyl)-piperazines as potent and orally active acetyl-CoA carboxylase 1/2 non-selective inhibitors: F-Boc and triF-Boc groups are acid-stable bioisosteres for the Boc group.
Topics: Acetyl-CoA Carboxylase; Administration, Oral; Animals; Fluorine; Formic Acid Esters; Molecular Structure; Piperazine; Piperazines; Piperidines; Rats; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues.
Topics: Amides; Animals; Anti-Bacterial Agents; Antidepressive Agents; Antifungal Agents; Antioxidants; Behavior, Animal; Candida albicans; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperazine; Piperazines; Piperidines | 2012 |
Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.
Topics: Anti-HIV Agents; Cell Line; Drug Discovery; HIV Integrase; HIV-1; Humans; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Models, Molecular; Oxyquinoline; Piperazine; Piperazines; Piperidines; Protein Binding; Protein Conformation; Structure-Activity Relationship | 2013 |
Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
Topics: Animals; Benzodioxoles; Enzyme Inhibitors; HEK293 Cells; Humans; Mice; Monoacylglycerol Lipases; Piperazine; Piperazines; Piperidines; Rats; Substrate Specificity; Triazoles; Urea | 2013 |
Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands.
Topics: Animals; Binding Sites; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Ligands; Male; Molecular Conformation; Piperazine; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Structure-Activity Relationship | 2013 |
O(2)-dependent efficacy of novel piperidine- and piperazine-based chalcones against the human parasite Giardia intestinalis.
Topics: Antiprotozoal Agents; Caco-2 Cells; Cell Survival; Chalcones; Giardia lamblia; Humans; Piperazine; Piperazines; Piperidines | 2014 |
One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Structure; Piperazine; Piperazines; Piperidines; Pyrimidines; Structure-Activity Relationship | 2014 |
Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Topics: Amides; Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Monoacylglycerol Lipases; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship | 2014 |
Anti-trypanosomal activities and structural chemical properties of selected compound classes.
Topics: Animals; Cell Line; Cysteine Proteases; Fumarates; Hydrogen-Ion Concentration; Macrophages; Mice; Mitochondria; Organelles; Piperazine; Piperazines; Piperidines; Trypanocidal Agents; Trypanosoma brucei brucei | 2015 |
Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library.
Topics: Combinatorial Chemistry Techniques; Drug Discovery; Heterocyclic Compounds; Lithium; Molecular Structure; Organometallic Compounds; Piperazine; Piperazines; Piperidines; Pyrrolidines; Small Molecule Libraries | 2015 |
Ozonation of piperidine, piperazine and morpholine: Kinetics, stoichiometry, product formation and mechanistic considerations.
Topics: Kinetics; Morpholines; Ozone; Pharmaceutical Preparations; Piperazine; Piperazines; Piperidines; Waste Disposal, Fluid; Water Pollutants, Chemical | 2016 |
Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines.
Topics: Calcitonin Gene-Related Peptide; Cell Line, Tumor; Cell Membrane Permeability; Humans; Indazoles; Inhibitory Concentration 50; Piperazine; Piperazines; Piperidines; Quinazolinones; Structure-Activity Relationship | 2016 |
Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages.
Topics: Antitubercular Agents; Cell Survival; Click Chemistry; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; Morpholines; Mycobacterium tuberculosis; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship; Thiophenes; Triazoles | 2016 |
Design and synthesis of bridged piperidine and piperazine isosteres.
Topics: Animals; Bridged Bicyclo Compounds; Crystallography, X-Ray; Dopamine Antagonists; Drug Design; ERG1 Potassium Channel; Humans; Magnetic Resonance Spectroscopy; Mice; Piperazine; Piperidines; Receptors, Dopamine D2; Receptors, Dopamine D4; Structure-Activity Relationship | 2018 |
Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Jurkat Cells; MCF-7 Cells; Melanoma, Experimental; Mice; Molecular Docking Simulation; Piperazine; Piperidines; Receptor, EphB3; Repressor Proteins | 2019 |
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors.
Topics: Agaricales; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Molecular Docking Simulation; Molecular Structure; Monophenol Monooxygenase; Piperazine; Piperidines | 2020 |
One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists.
Topics: Click Chemistry; Humans; Molecular Structure; Piperazine; Piperidines; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2019 |
Selective acetylcholinesterase inhibitors derived from muscle relaxant dantrolene.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Dantrolene; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Muscle Relaxants, Central; Piperazine; Piperidines; Structure-Activity Relationship | 2020 |
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.
Topics: Binding Sites; Catalytic Domain; Drug Design; Enzyme Inhibitors; Humans; Indoles; Kinetics; Molecular Docking Simulation; Nicotinamide Phosphoribosyltransferase; Piperazine; Piperidines | 2020 |
Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
Topics: Amides; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Ligands; Molecular Structure; Piperazine; Piperidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia; Structure-Activity Relationship | 2020 |
The tea-bag protocol for comparison of Fmoc removal reagents in solid-phase peptide synthesis.
Topics: Green Chemistry Technology; Peptides; Piperazine; Piperidines; Solid-Phase Synthesis Techniques | 2020 |
Structural modifications in the distal, regulatory region of histamine H
Topics: Animals; Anti-Obesity Agents; Body Weight; Dose-Response Relationship, Drug; Female; Histamine H3 Antagonists; Humans; Imidazoles; Ligands; Models, Molecular; Piperazine; Piperidines; Protein Binding; Rats, Wistar; Receptors, Histamine H3; Regulatory Sequences, Nucleic Acid; Structure-Activity Relationship | 2021 |
Sialic Acid 4-N-Piperazine and Piperidine Derivatives Bind with High Affinity to the P. mirabilis Sialic Acid Sodium Solute Symporter.
Topics: N-Acetylneuraminic Acid; Piperazine; Sodium; Symporters | 2022 |